In a crucial step towards transforming healthcare financial operations, AKASA, the leading provider of generative AI solutions for the healthcare revenue cycle, has successfully raised $120 million in its latest funding round. With healthcare revenue cycle teams facing unprecedented pressures—marked by rising volumes, constricting margins, and challenges in staffing—AKASA’s innovative technology is more important than ever. The funds will be utilized to enhance the capabilities of the AKASA platform, which seamlessly integrates proprietary generative AI technology with deep revenue cycle expertise. This approach allows the AI to be fine-tuned on a health system’s own clinical data, thereby equipping it to understand and address the unique challenges posed by individual healthcare environments. With the remarkable ability to decrease accounts receivable days by 13%, achieve an astounding 86% improvement in efficiency, and save over 300 hours of staff time monthly, AKASA’s solutions have already made a significant impact—contributing an impressive $30 million increase in gross yield for healthcare providers. Backed by a group of high-profile investors, including Andreessen Horowitz and Costanoa Ventures, AKASA has raised over $200 million to date. The recent funding will further fuel the company’s mission to eliminate the financial complexities of healthcare through AI, paving the way for a more efficient and patient-centered future. We are excited to reshape the healthcare revenue cycle landscape and invite you to join us on this transformative journey. Let's chat!

Innovative Healthcare AI Company AKASA Secures $120M in Funding to Revolutionize Revenue Cycle Management
Get the full Akasa company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
P2 Science, Inc.
We are the New Green Chemistry Company with a mission to de-carbonize the chemical industry, using the power of green chemistry.
$23.0M Unknown
today

Backoffice Solutions, Inc.
Backoffice Solutions, Inc. (BSI) is a domestic corporation that offers back-office support to micro, small and medium Enterprises, sole proprietors or self-employed individuals. Registered under the Securities Exchange Commission (SEC) since 14 August 2012. Our company has worked with varied private sector companies and organizations, allowing us to develop expertise in the following sectors: * Online Market Place * Restaurants and Food Chains * Forwarding Business * Travel & Tours * Advertising & Marketing * Domestic Manpower Agency * Hotels, Resorts & Tourism * International Manning Agency * Training School * Ship Management
$163.5K Unknown
today

Evolve Neuro
Transforming ADHD diagnosis with proprietary neuroscience and AI. Our 10-minute EEG-based assessment unlocks scalable, evidence-backed insights — targeting a global market underserved by outdated, subjective methods.
$1.9M Seed
today

Phytolon
Phytolon offers natural food colors, uniquely positioned to comply with the consumers needs for healthy food, and with the industry requirements for cost-efficiency and high quality. Phytolon leverages a novel and sustainable fermentation-based technology by which betalain natural colors are produced in baker's yeast.
$23.6M Series b
today

OZOREON
Our (H)unit® is a robust offgrid adapted ozone generator, built to last. With proprietary components and design it can withstand any humidity in the feed gas. We offer it as a stand-alone product or included in an automation cabinet. As an add-on we also provide a customized offgrid power-supply kit. The beneficial combination of ozone and high humidity is a known fact in the industry, and has been documented for 80+ years. The synergistic effects causes higher oxidizing and disinfecting properties than a dry ozone treatment does. And OZOREON has the technology for it.
$320.0K Unknown
today